Novo Nordisk
NVO
886 hedge funds and large institutions have $14.7B invested in Novo Nordisk in 2021 Q4 according to their latest regulatory filings, with 150 funds opening new positions, 264 increasing their positions, 294 reducing their positions, and 57 closing their positions.
163% more first-time investments, than exits
New positions opened: 150 | Existing positions closed: 57
112% more call options, than puts
Call options by funds: $169M | Put options by funds: $79.7M
77% more funds holding in top 10
Funds holding in top 10: 13 → 23 (+10)
16% more capital invested
Capital invested by funds: $12.7B → $14.7B (+$2.04B)
10% more funds holding
Funds holding: 804 → 886 (+82)
0.04% less ownership
Funds ownership: 14.91% → 14.87% (-0.04%)
10% less repeat investments, than reductions
Existing positions increased: 264 | Existing positions reduced: 294
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
+$269M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$57.8M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$56.9M |
| 4 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$21.7M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$19.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$273M |
| 2 |
Millennium Management
New York
|
-$59.5M |
| 3 |
Two Sigma Investments
New York
|
-$47.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$33.8M |
| 5 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$32M |
NVO Hedge Fund Activity: Q4 2021 in Review
886 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2021, worth a combined $14.7B — up 16% from $12.7B a quarter earlier.
Buyers outnumbered sellers: 150 funds opened new NVO positions and 57 closed out — a net gain of 93 holders — while 264 added to existing stakes and 294 trimmed.
The largest buyer was WCM Investment Management, opening a new position worth an estimated $269M. The largest seller was Renaissance Technologies, cutting an estimated $273M.
- 886 institutional investors held Novo Nordisk (NVO) as of Q4 2021, up from 804 in Q3 2021.
- Funds reported $14.7B of Novo Nordisk stock for Q4 2021, up 16% quarter-over-quarter.
- 150 funds opened new Novo Nordisk positions in Q4 2021 and 57 closed out, a net change of +93 holders.
- The largest Novo Nordisk buyer in Q4 2021 was WCM Investment Management, an estimated $269M added.
- The largest Novo Nordisk seller in Q4 2021 was Renaissance Technologies, an estimated $273M sold.
Based on aggregated 13F filings for Q4 2021.